{"id":"W4383186826","doi":"10.55563/clinexprheumatol/8l7bbk","title":"Upadacitinib in patients with psoriatic arthritis and inadequate response to biologics: 3-year results from the open-label extension of the randomised controlled phase 3 SELECT-PsA 2 study","year":2023,"lang":"en","type":"article","venue":"Clinical and Experimental Rheumatology","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"ca_institutions":"Merck Canada Inc. (Canada); Probity Medical Research","funders":"Celgene; Pfizer; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Medicine; Psoriatic arthritis; Internal medicine; Adverse effect; Population; Rheumatology; Psoriasis; Placebo; Arthritis; Surgery; Immunology; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000932369,0.0001779366,0.001051949,0.0000436685,0.0001721237,0.00001750155,0.0001264216,0.00008503125,0.00001394853],"category_scores_gemma":[0.002393691,0.00008471398,0.00004734266,0.000230804,0.000353593,0.00003339162,0.0003418058,0.0001513781,0.000008958548],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00001354695,"about_ca_system_score_gemma":0.00004031866,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003205452,"about_ca_topic_score_gemma":0.0001031749,"domain_scores_codex":[0.9975636,0.0007488352,0.0008494372,0.000457603,0.0001490738,0.0002314308],"domain_scores_gemma":[0.9968274,0.002509527,0.0001939566,0.0003049836,0.00006136579,0.0001027193],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.6469725,0.004631228,0.3365062,0.000003487308,0.0003472954,0.0000583334,0.002262548,2.902844e-7,0.000207103,0.00001947248,0.0004626791,0.008528833],"study_design_scores_gemma":[0.6149371,0.009641544,0.3714568,0.0002258282,0.00005164179,0.000006882618,0.003298707,0.00003084236,0.0001638762,0.00003734686,0.00005991954,0.00008956737],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9938935,0.0009722682,3.404261e-7,0.001132072,0.0001927486,0.003688924,0.00007827415,0.00001597442,0.00002586447],"genre_scores_gemma":[0.9988994,0.000428154,0.00005751126,0.0002843129,0.000008907259,0.0002499176,0.00003093734,0.00001187536,0.00002899519],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.03495062,"threshold_uncertainty_score":0.3454536,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04481288090633665,"score_gpt":0.3672352585096877,"score_spread":0.322422377603351,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}